| Gene Symbol | CAV1 |
| Aliases | Caveolin 1, Caveolin-1 |
| Protein Type | Structural Protein |
| Target Class | Structural Protein |
| Function | No established drugging mechanism for structural membrane protein |
| Mechanism of Action | No established drugging mechanism for structural membrane protein |
| Druggability | Low (0.35) |
| Clinical Stage | Approved |
| Molecular Weight | 22 kDa |
| Pathways | MAPK pathway, PI3K |
| UniProt ID | Q2TNI1 |
| GeneCards | CAV1 |
| Human Protein Atlas | CAV1 |
| Scaffolding domain ( residues 82-101) | Critical for protein-protein interactions and signaling regulation |
| Oligomerization domain (residues 1-97) | Mediates formation of high-molecular-weight complexes |
| Associated Diseases | Als, Alzheimer, Anxiety, atherosclerosis |
| Known Drugs/Compounds | Daidzein |
| Interactions | ABCB1, Actin, ADAMTS1, Adiponectin, AGO2, Akt |
| SciDEX Target | View Target Profile (1 clinical trials) |
| KG Connections | 503 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
No AI portrait yet
No comments yet. Be the first to comment!
No comments yet. Be the first to comment!